PULMONX CORPORATION - COMMON STOCK

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

20 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

07 نوفمبر 2024 16:05:01 بحسب Nasdaq GlobeNewswire

Pulmonx to Present at the Stifel 2024 Healthcare Conference

05 نوفمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Reports Third Quarter 2024 Financial Results

30 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

16 أكتوبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Announces Presentation of Clinical Data from the AeriSeal® CONVERT Trial and 5-Year Follow-up Data from the LIBERATE Study at the European Respiratory Society Congress 2024

09 سبتمبر 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Participate in the Lake Street 8th Annual Best Ideas Growth Conference

29 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Present at the 2024 Wells Fargo Healthcare Conference

22 أغسطس 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Reports Second Quarter 2024 Financial Results

31 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Present at the Canaccord Genuity 44th Annual Growth Conference

29 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Report Second Quarter 2024 Financial Results on July 31, 2024

10 يوليو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

06 مايو 2024 17:03:06 بحسب Nasdaq GlobeNewswire

Pulmonx Reports First Quarter 2024 Financial Results

01 مايو 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Report First Quarter 2024 Financial Results on May 1, 2024

10 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Announces Appointment of Mehul Joshi as Chief Financial Officer

02 أبريل 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

15 مارس 2024 17:00:37 بحسب Nasdaq GlobeNewswire

Pulmonx Reports Fourth Quarter and Full Year 2023 Financial Results

21 فبراير 2024 16:06:00 بحسب Nasdaq GlobeNewswire

Pulmonx Announces Retirement of CEO Glen French and Appointment of Industry Veteran Steve Williamson as President and Chief Executive Officer

21 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Report Fourth Quarter and Full Year 2023 Financial Results on February 21, 2024

07 فبراير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

Pulmonx to Present at the Piper Sandler 35th Annual Healthcare Conference

15 نوفمبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire